District Court Amicus Brief of the National Legislative Association on Prescription Drug Prices, the New Hampshire Medical Society, and Prescription Policy Choices in Support of Defendant's Objection to Plaintiff's Motion for Preliminary Injunction

2006 ◽  
Author(s):  
Sean M. Flynn ◽  
Derek D. Lick
Keyword(s):  
Prescription Drug ◽  
New Hampshire ◽  
Medical Society ◽  
District Court ◽  
Policy Choices ◽  
Drug Prices ◽  
Preliminary Injunction

In the Aftermath of the “Myriad Case” – Myriad Is Denied Preliminary Injunction Against Ambry Genetics

2014 ◽  
Vol 5 (3) ◽  
pp. 407-412
Author(s):  
Emanuela Gambini
Keyword(s):  
Dna Sequences ◽  
Case Note ◽  
District Court ◽  
Central Division ◽  
University Of Utah ◽  
Synthetic Dna ◽  
Preliminary Injunction ◽  
The U.S

On March 10, 2014, the U.S. District Court of Utah, Central Division, decided in University of Utah Research Foundation, et al., v. Ambry Genetics Corporation, holding that “Plaintiffs are not entitled to a preliminary injunction”, as they “are unable to establish that they are likely to succeed on the merits of the claims” nor “that the equitable factors support issuance of the requested injunction”.This case note gives an overview of the U.S. District Court's of Utah memorandum decision and order denying plaintiffs’ motion for preliminary injunction and discusses its implications for the implementation of the criterion of isolation to “synthetic” DNA sequences, such as primers and probes.

scholarly journals Specialty Prescription Drug Prices Continue to Climb

2021 ◽  
Author(s):  
Stephen W. Schondelmeyer ◽  
Leigh Purvis
Keyword(s):  
Prescription Drug ◽  
Drug Prices
Sign in / Sign up

Export Citation Format

Share Document